These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9584026)

  • 1. Norplant coercion.
    Brady M
    Am J Public Health; 1998 Jan; 88(1):136-7. PubMed ID: 9584026
    [No Abstract]   [Full Text] [Related]  

  • 2. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topics for our times: Norplant coercion--an overstated threat.
    Davidson AR; Kalmuss D
    Am J Public Health; 1997 Apr; 87(4):550-1. PubMed ID: 9146429
    [No Abstract]   [Full Text] [Related]  

  • 4. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE
    Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical analysis of the constitutional and legal infirmities of Norplant as a condition of probation.
    Ballard MJ
    Wis Womens Law J; 1992-1993; 7-8():85-106. PubMed ID: 16617538
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Norplant experience in Zaria: a ten-year review.
    Haggai DN
    Afr J Reprod Health; 2003 Aug; 7(2):20-4. PubMed ID: 14677296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acceptability of norplant implantation in China].
    Gu SJ
    Zhonghua Fu Chan Ke Za Zhi; 1989 Sep; 24(5):291-4, 317-8. PubMed ID: 2515944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Norplant contraceptive on the bones of Nigerian women as assessed by quantitative ultrasound and serum markers of bone turnover.
    Vanderjagt DJ; Sagay AS; Imade GE; Farmer SE; Glew RH
    Contraception; 2005 Sep; 72(3):212-6. PubMed ID: 16102558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the pre-introduction of contraception by means of subcutaneous levonorgestrel implants in Burkina Faso].
    Lankoande J; Ouedraogo A; Dao B; Ouedraogo CM; Bonane B; Toure B; Ouattara T; Kabore I; Millogo B; Kone B
    Dakar Med; 1998; 43(1):79-82. PubMed ID: 9827162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norplant: a new contraceptive.
    Flattum-Riemers J
    Am Fam Physician; 1991 Jul; 44(1):103-8. PubMed ID: 1905473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M; Fraser I; Dwarte D; Graham S
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable levonorgestrel contraception: 4 years of experience with Norplant.
    Hatasaka H
    Clin Obstet Gynecol; 1995 Dec; 38(4):859-71. PubMed ID: 8616982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.